NOK mediates glycolysis and nuclear PDC associated histone acetylation

Area of Science:

• Molecular Oncology
• Cancer Metabolism
• Epigenetics

Background:

• The oncogene NOK is known to transform normal cells into cancer cells.
• The precise mechanisms by which NOK influences cancer cell metabolism and epigenetic modifications remain largely unexplored.

Purpose of the Study:

• To investigate the impact of the oncogene NOK on cancer cell metabolism, specifically focusing on mitochondrial function and glycolysis.
• To determine if NOK influences histone acetylation through mitochondrial-nuclear signaling pathways.

Main Methods:

• Localization studies to determine NOK's subcellular distribution.
• Metabolic assays to assess the tricarboxylic acid (TCA) cycle, electron transport chain, and oxidative phosphorylation.
• Measurement of aerobic glycolysis rates.
• Analysis of pyruvate dehydrogenase complex (PDC) translocation from mitochondria to the nucleus.
• Assessment of nuclear histone acetylation levels.

Main Results:

• NOK was found to localize within the mitochondria of cancer cells.
• NOK minimally affected the TCA cycle but significantly inhibited electron transport and oxidative phosphorylation.
• NOK dramatically enhanced aerobic glycolysis and promoted the mitochondrial-nuclear translocation of PDC.
• Increased histone acetylation was observed in the nucleus following NOK expression.

Conclusions:

• The oncogene NOK plays a critical role in reprogramming cancer cell metabolism by inhibiting oxidative phosphorylation and enhancing aerobic glycolysis.
• NOK mediates epigenetic modifications, specifically histone acetylation, through the translocation of PDC to the nucleus.
• These findings elucidate novel functions of NOK in cancer progression, linking metabolic reprogramming to epigenetic alterations.